Spironolactone and hydrochlorothiazide (spironolactone and hydrochlorothiazide)

Approved for Spironolactone, an ingredient of spironolactone and hydrochlorothiazide tablets, has been shown to be a tumorigen in chronic toxicity studies in rats (see Precautions section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug should be avoided. Spironolactone and hydrochlorothiazide tablets are…

Loading full data from Know Your Drugs Institute…